Skip To Content

With Sackler Lawsuits Heating Up The Met Will Review Its Donor Policy

Following a new complaint against Purdue Pharma brought by the State of Massachusetts, the Metropolitan Museum of Art is reviewing its gift acceptance policy.

The court filing, reported on by The New York Times last week, alleges that the Sackler family, the founders of Purdue Pharma and longtime donors to the Met, directed a misinformation campaign designed to pin the blame of OxyContin deaths on addicts and to encourage the drug’s over-prescription. Using internal documents, including emails, the 312-page filing includes the first evidence that links the Sacklers to marketing decisions behind OxyContin.

“The Sackler family has been connected with The Met for more than a half century,” Daniel Weiss, the museum’s president and CEO said in a statement. “The family is a large extended group and their support of The Met began decades before the opioid crisis. The Met is currently engaging in a further review of our detailed gift acceptance policies, and we will have more to report in due course.”

Purdue Pharma, and the Sacklers in particular, have been under scrutiny in the art world since early last year. Photographer Nan Goldin’s group PAIN Sackler, founded to draw attention to the family’s alleged involvement in the opioid epidemic, has turned its protest into performance art by staging “die-ins” at art institutions housing wings and collections bearing the Sackler family name.

In March of 2018, PAIN Sackler [went to the Met’s Sackler Wing]( There, near the Roman Period Egyptian Temple of Dendur, protestors lay on the ground and threw fake prescription bottles into the reflecting pool. The Sackler Wing was founded in 1978 with money from Purdue Pharma co-founders, brothers Raymond, Mortimer and Arthur Sackler, the last of whom died in 1987, eight years before OxyContin was developed.

“None of the charitable donations made by Arthur prior to his death, nor that I made on his behalf after his death, were funded by the production, distribution or sale of OxyContin or other revenue from Purdue Pharma. Period,” Jillian Sackler, Arthur Sackler’s widow said in a statement following the March protest The Art Newspaper reported.

Jillian Sackler and her children are not defendants in the Massachusetts lawsuit, but eight relatives and widows of Raymond and Mortimer Sackler are. In New York, where the Met is based, a separate, $500 million lawsuit claiming Purdue Pharma is partially responsible for the opioid crisis, names Sackler family members who were on the board of the company in the 1990s when OxyContin came on the market.

Among the defendants in both cases is Richard Sackler, Raymond’s son, who is alleged in the Massachusetts filing to have told sales representatives to advise doctors to prescribe the maximum dosage of OxyContin.

In a confidential email from 2001 cited in the complaint, Richard Sackler appeared to suggest a strategy to control the narrative of the drug amid growing of overdoses and deaths by blaming victims. “We have to hammer on abusers in every way possible,” Sackler wrote. “They are the culprits and the problem. They are reckless criminals.”

PJ Grisar is the Forward’s culture intern. He can be reached at [email protected].

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.